MetLife Investment Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $583K | Hold |
|
|||||
|
2025
Q2 | $275K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $39.1K | Sell |
|
|||||
|
2023
Q4 | $393K | Hold |
|
|||||
|
2023
Q3 | $489K | Hold |
|
|||||
|
2023
Q2 | $576K | Hold |
|
|||||
|
2023
Q1 | $784K | Hold |
|
|||||
|
2022
Q4 | $987K | Buy |
|
|||||
|
2022
Q3 | $548K | Buy |
|
|||||
|
2022
Q2 | $131K | Hold |
|
|||||
|
2022
Q1 | $87.2K | Buy |
|